Trial intelligence / Profile preview

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis

NCT02653339Unknown

Sponsor
Peking Union Medical College Hospital
Start
Jun 2016
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of Qufeng Shengshi Fang in allergic rhinitis (AR) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Improvement clinical symptoms of Allergen Rhinitis at 8 weeks. Status: unknown.

02

Drugs

Qufeng Shengshi Fang
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT02653339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02653339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call